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Hydroxychloroquine Modulates Metabolic Activity
and Proliferation and Induces Autophagic Cell Death
of Human Dermal Fibroblasts
Bettina Ramser1, Agatha Kokot1, Dieter Metze1, Nina Weiß1, Thomas A. Luger1 and Markus Bo¨hm1
Hydroxychloroquine (HCQ) is a commonly used therapeutic agent in skin disorders. Some reports also suggest
that HCQ can be useful in fibroblastic diseases of the skin. Here, we investigated the effects of HCQ in human
dermal fibroblasts (HDFs). HCQ significantly reduced the metabolic activity and suppressed cell proliferation
(IC50 ¼ B30 mM) of HDFs. The antiproliferative effect of HCQ was associated with decreased activation of the
extracellular signal-regulated kinases 1/2 but not with inhibition of the mammalian target of the rapamycin
pathway or with dephosphorylation of Akt. HCQ induced a distinct type of cell death in HDFs, characterized by
surface exposure of phosphatidylserine but a lack of morphological signs of apoptosis and absence of DNA
fragmentation. The HCQ-treated HDFs instead showed autophagic vacuoles with double membranes and
digested organelle content. These vacuoles showed light-chain 3 immunostaining, in accordance with increased
protein amounts of this autophagy marker. Induction of autophagic cell death by HCQ was also paralleled by
increased expression of Beclin-1, a key regulator of autophagy. Our findings indicate that HDFs are target cells
of HCQ and form a rationale on the basis of which the in vivo effects of antimalarials can be studied in patients
with aberrant fibroblast function.
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INTRODUCTION
Antimalarials such as chloroquine (CQ) and hydroxychlor-
oquine (HCQ) are used routinely in many inflammatory skin
diseases (Wolf et al., 2000). In addition to their ‘‘classic’’
indication, lupus erythematosus, there are skin diseases with
altered fibroblast function, for example, localized scleroder-
ma (Wuthrich et al., 1975; Su and Greene, 1986; Nagy and
Lada´nyi, 1987; Brownell et al., 2007), sclerodermic linear
lupus panniculitis (Marzano et al., 2005), and mucinoses
(Balogh et al., 1980; Terheyden et al., 2003), in which these
agents may be of some benefit.
These observations prompted us to examine the effects of
HCQ in human dermal fibroblasts (HDFs) in more detail.
Owing to their basic nature, both CQ and HCQ are highly
accumulated in specific cellular compartments, in particular
in the lysosomes, where they can reach millimolar levels and
shift the pH of these organelles toward neutral (MacIntyre and
Cutler, 1988). With regard to the skin, it has further been
shown that both CQ and HCQ are deposited in microgram
amounts per gram of skin (Shaffer et al., 1958).
The potential mechanisms underlying the beneficial
effects of antimalarials in skin diseases are complex, partially
contradictory, and incompletely understood. However, it was
shown that CQ suppresses the proliferation of fetal lung
fibroblasts (Hauss et al., 1979) and basic fibroblast growth
factor (bFGF)- or serum-induced mitogenicity in microvas-
cular endothelial cells (Inyang et al., 1990). Other studies
showed that CQ or HCQ induces apoptosis of umbilical
vascular endothelial cells (Potvin et al., 1997), peripheral
blood lymphocytes (Meng et al., 1997; Lagneaux et al.,
2002), and rheumatoid synoviocytes (Kim et al., 2006). With
regard to the modulation of proinflammatory cytokines,
mostly inhibitory effects of CQ and HCQ were detected.
Depending on the cell type, HCQ or CQ inhibited the
production of IL-1a/b, IL-6, and tumor necrosis factor-a
(Sperber et al., 1993; Bondeson and Sundler, 1998; Seitz
et al., 2003). However, CQ was found to induce IL-1a
production in endothelial cells (Potvin et al., 1997).
In this report we investigated the in vitro impact of
HCQ on HDFs. Our findings indicate that this cutaneous cell
type is a target for HCQ as shown by its modulatory effects on
cell proliferation and survival. HCQ induces a distinct type
of cell death—autophagy—which is associated with the
induction of Beclin-1 and LC3, both markers of autophagic
cell death.
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RESULTS
HCQ suppresses metabolic activity, proliferation, and
phosphorylation of extracellular signal-regulated kinase 1/2 in
HDFs
We first examined the effects of HCQ on the metabolic activity
and proliferation of HDFs by sodium 30-[1-(phenylaminocar-
bonyl)-3,4-tetrazolium]-bis(4-methoxy-6-nitro) benzene sulfo-
nic acid hydrate (XTT) test and by 3[H]-thymidine incorporation.
Initial experiments with trypan blue exclusion showed that
exposure of HDFs to HCQ decreased the cellular viability at
concentrations beyond 10mM (data not shown). HCQ led to a
dose-dependent decrease in metabolic activity (IC50¼ 27mM)
and cell proliferation (IC50¼30mM) (Figure 1a and b). We next
examined the mitogen-activated protein kinase (MAPK) and
mammalian target of rapamycin (mTOR) pathway, both key
regulatory pathways of metabolic activity and mitogenicity.
Using the MAPK kinase (MEK) inhibitor PD98059 (10mM) as a
control, we found that HCQ (30mM) induced a marked and
time-dependent decrease in ERK1/2 phosphorylation at Thr202/
Tyr204 even after 48hours exposure (Figure 1c), suggesting that
ERK1/2 inhibition mediates the HCQ-induced inhibition of
metabolic activity and proliferation. However, when PD98059
was tested in an XTT assay, PD98059 at 5 or 10mM (data not
shown) had only weak effects (Figure 1d). Co-incubation of
HCQ at various doses did not further increase the inhibitory
effect of HCQ on metabolic activity of HDFs (Figure 1d). These
findings indicate that the inhibitory effect of HCQ on ERK1/2
may be much stronger than that of PD98059, or that HCQ
utilizes additional pathways of growth inhibition, for example,
induction of cell-death pathways.
When activation of S6 ribosomal protein was measured as
a surrogate marker for S6 kinase and mTOR activity, the
mTOR inhibitor everolimus (1 nM) reduced the extent of
Ser240/244 phosphorylation in untreated HDFs and those
exposed to the mitogen bFGF. Interestingly, HCQ (like bFGF)
failed to reduce S6 phosphorylation; in fact, it increased it
(Figure 1e). We also determined the phosphorylation state of
Akt, a protein kinase activated by various growth factors and
survival factors. In HDFs cultured in the presence of 2% FCS,
in which HCQ reduced proliferation and decreased MAPK
phosphorylation (Figure 1a–c), Akt phosphorylation was
undetectable (data not shown). When HDFs were stimulated
with platelet-derived growth factor (PDGF), marked Akt
phosphorylation at Thr308 and Ser473 occurred (Figure 1f).
However, in contrast to the phosphatidylinositol 3-kinase
inhibitor wortmannin (100 nM), HCQ (30 mM) did not affect
Akt phosphorylation (Figure 1f).
HCQ induces a distinct type of cell death in HDFs in vitro
To explore the anti-proliferative mechanism of HCQ in
HDFs, we next employed a panel of apoptotic cell-death
readout systems, including Annexin-V staining, cell-death
detection, and DNA fragmentation assay. Using staurospor-
ine (STS) as a positive control for apoptosis (Ferraris et al.,
1997), we found an increase in the extent of Annexin-V
surface staining in HDFs exposed for 24 hours to HCQ at
doses as low as 1 mM (Figure 2a). At 30 mM HCQ, the extent of
Annexin-V staining was comparable to that of 0.5 mM STS
(Figure 2b). Surprisingly, HCQ in HDFs did not induce robust
formation of mono- and oligonucleosomes as demonstrated
by cell-death detection ELISA. HCQ amounts that resulted in
Annexin-V staining (10 or 30 mM) failed to induce mono- and
oligonucleosomes after 24 hours (Figure 2c). At the highest
doses tested (50 and 100mM), HCQ induced some mono- and
oligonucleosome formation. However, compared with the
robust signal induced by STS, this effect of HCQ was
marginal (Figure 2c). In accordance with the observed lack
of a robust effect of HCQ on mono- and oligonucleosome
formation, DNA fragmentation assays for HCQ did not show a
clear-cut DNA degradation in HDFs, whereas those for STS did
(Figure 2d). These findings show that HCQ in HDFs induces a
distinct type of cell death characterized by surface exposure of
phosphatidylserine but not by DNA fragmentation.
HCQ induces autophagy in HDFs in vitro
As HCQ has lysosomotropic properties (MacIntyre and
Cutler, 1988), we next investigated the morphological and
ultrastructural changes of HDFs exposed to HCQ. Dose- and
time-kinetic investigations showed that cytoplasmic vacuoli-
zation occurred upon exposure of HDFs to HCQ at
concentrations as low as 1 mM after 72 hours (data not shown).
However, vacuolization at light-microscopic level was most
apparent at HCQ doses above 10 mM, at which multiple round
vacuoles developed as early as 3 hours after exposure (Figure
3a). HCQ-induced vacuolization was not restricted only to
HDFs; HaCaT cells, an epidermal keratinocyte-derived
immortalized cell line, also exhibited vacuoles upon HCQ
treatment (Figure 3b). It should be noted that HCQ-induced
vacuolization was not detected in HDFs exposed to the MEK
inhibitor PD98059, suggesting that this process involves
additional pathways (Figure 3b).
As shown by Giemsa staining, HCQ-induced vacuoliza-
tion was not paralleled by classical signs of apoptosis, that is,
no pyknosis, cell shrinkage, or chromatin condensation, as
observed after exposure to 0.1 mM STS (Figure 3c). To further
characterize HCQ-induced cytoplasmic vacuoles, electron
microscopy was performed. In untreated HDFs (as well as in
cells treated with both HCQ and STS), some cytoplasmic
vacuoles were seen; these were attributed to starvation of
these cells under reduced serum (2% FCS) in the culture
medium. Treatment of HDFs with HCQ for 8 hours resulted in
multiple autophagosomes with double membranes and
digested organelles at various stages (Figure 3d). In accor-
dance with the light microscopic findings, STS-treated HDFs
lacked double-membrane vacuoles but displayed chromatin
condensation, fragmentation, and apoptotic bodies (Figure
3d). To further elucidate the nature of the HCQ-induced
vacuoles, immunofluorescence analysis of HDFs with an
antibody (Ab) against the microtubule-associated protein
light-chain 3 (LC3) was performed. It had been reported that
autophagosomes contain high concentrations of LC3, which
is recruited to and then maintained in the membranes of
autophagic vacuoles (Kabeya et al., 2000). Treatment
with HCQ (30 mM) for 16 hours led to a bright vesicular
LC3B staining within the cytoplasm of HDFs, while
untreated cells remained negative (Figure 3e). The increased
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immunofluorescence of LC3B in HCQ-exposed fibroblasts
seemed to be due to an enhanced protein expression of the
LC3B-II form (Figure 3f), which corresponds to autophago-
some formation (Kabeya et al., 2000). These findings show
that HCQ in vitro induces autophagic cell death in HDFs.
This type of cell death is morphologically and—based on our
previous apoptosis readout systems—mechanistically distinct
from bona fide apoptosis.
HCQ induces expression of Beclin-1, an autophagy regulator, in
HDFs in vitro
Given that Beclin-1, a Bcl-2-interacting protein with structur-
al similarity to the yeast autophagy gene apg6/vps30, is
crucially involved in the initial step of autophagosome
formation (Liang et al., 1999), we wondered whether HCQ
induces Beclin-1 in HDFs. Treatment of cells with HCQ
(30 mM) for 6 hours significantly increased the mRNA levels
of Beclin-1 as shown by real-time PCR (Figure 4a).
Western immunoblotting confirmed increased amounts of
Beclin-1 protein, but not of the related apoptotic regulator
Bcl-2, after exposure of HDFs to HCQ for 12–16 hours
(Figure 4b). In accordance with this finding, Beclin-1
immunoreactivity was detected in HCQ-treated HDFs (Figure
4c). As reported before in COS7 and MCF7 cells (Liang et al.,
2001), Beclin-1 appeared as a granular cytoplasmic staining,
whereas in untreated HDFs only a weak and diffuse
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Figure 1. Hydroxychloroquine (HCQ) suppresses metabolic activity, proliferation, and extracellular signal-regulated kinase ERK1/2 activation, but not the S6
ribosomal protein or Akt phosphorylation in human dermal fibroblasts (HDFs). (a) Metabolic activity as measured by XTT test. Cells were incubated with HCQ
for 48 hours; *Po0.0001, **Po0.00001. (b) Cell proliferation as measured by 3[H]-thymidine incorporation. HDFs were incubated with HCQ for 48 hours;
*Po0.05, **Po0.01, ***Po0.001 versus control. (c) HCQ time-dependently decreases ERK1/2 phosphorylation at Thr202/Tyr204. Cells were treated with HCQ
(30mM) or with PD98059 (10mM) as indicated. ERK1/2 phosphorylation was determined by western immunoblotting using a phosphospecific antibody (Ab)
followed by stripping and reprobing with an anti-ERK1/2 Ab. (d) Effect of combined HCQ and PD98059 treatment on metabolic activity of HDFs. Cells were
treated with HCQ alone or in combination with PD98059 (5 mM) for 48 hours, followed by XTT test; *Po0.05, **Po0.001, ***Po0.00001 versus control. (e and
f). HCQ does not alter Akt (Thr308 and Ser473) and S6 ribosomal protein phosphorylation. Cells were treated with basic fibroblast growth factor (bFGF) (10 ng/
ml), HCQ (30 mM), and everolimus (EV, 1 nM) or with platelet-derived growth factor (PDGF) (20 ng/ml), HCQ (30mM), and wortmannin (100 nM) for 10minutes.
Phosphorylation of S6 ribosomal protein and Akt was determined by western immunoblotting using phosphospecific Abs. Equal amounts of proteins were
ensured by stripping and reprobing with an anti-a-tubulin Ab.
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immunoreactivity was detected. These findings show that
HCQ induces the autophagic regulator Beclin-1 at both the
RNA and the protein levels in HDFs, suggesting that
autophagy triggered by this antimalarial is mediated via
Beclin-1.
DISCUSSION
In this study we investigated the effect of HCQ on metabolic
activity, proliferation, and cell death of HDFs. Our in vitro
study was inspired by the fact that HCQ is frequently used in
inflammatory skin diseases although its precise mechanism of
action is incompletely understood. There is also interest in
the use of antimalarials such as HCQ in fibrosclerotic
diseases as well as in the co-treatment of therapy-refractory
inflammatory skin disorders, for example, chronic graft-
versus-host disease (Schultz and Gilman, 1997; Gilman
et al., 2000). Indeed, it has previously been shown that the
growth of fetal lung fibroblasts and endothelial cells is
inhibited by CQ (Hauss et al., 1979; Inyang et al., 1990).
However, the specific effects of HCQ (and CQ) may vary
among different cell types, and, to the best of our knowledge,
the precise mechanism of the effect of HCQ on growth and
survival of HDFs has not yet been addressed.
Our mechanistic studies on the impact of HCQ on HDF
proliferation revealed that the drug suppresses ERK1/2
phosphorylation. It was shown by others that lipopolysac-
charide-induced phosphorylation of ERK1/2 as well as the
activation of its upstream kinases MEK and Raf are inhibited
by CQ in peripheral blood mononuclear cells (Weber et al.,
2002). However, CQ suppressed the anti-CD29-induced
aggregation of U937 cells in an ERK-independent manner
(Cho, 2008). Therefore, further studies are needed to define
the precise mechanism used by HCQ to reduce phosphor-
ylation of ERK1/2 in HDFs.
As shown by our morphological, ultrastructural, and
apoptosis studies, the growth-inhibitory effect of HCQ in
HDFs is attributed to the induction of a distinct type of cell
death, namely, autophagy. This autophagic cell death
induced by HCQ in HDFs was confirmed by the appearance
of multiple cytoplasmic vacuoles with double membranes
and digested organelle content, as well as by the detection of
increased amounts of LC3B-II and induction of Beclin-1.
Boya et al. (2005) likewise reported that HCQ induces a
specific type of cell death in HeLa cells. The HCQ-induced
increase in the acidic vacuolar compartment was an up-
stream preapoptotic event that occurred before Dcm dissipa-
tion, cytochrome c translocation, and phosphatidylserine
exposure. Interestingly, it was shown that HCQ-induced
autophagic vacuole accumulation per se is not sufficient to
induce cell death, but that the point of no return for cell death
is related to the loss of Dcm and the presence of empty
apoptotic vacuoles.
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Figure 2. Hydroxychloroquine (HCQ) induces phosphatidylserine translocation but no DNA fragmentation in HDFs. (a and b) Annexin-V staining was
determined by FACS analysis. Cells were treated with HCQ as indicated for 24 hours. Staurosporine (STS) (0.5 mM) was used as positive control; *Po0.01,
**Po0.002, ***Po0.0001. (c) Effect of HCQ on mono- and oligonucleosome formation in HDFs after 24 hours as determined by cell-death detection ELISA;
*Po0.001, **Po0.0001. (d) Effect of HCQ on DNA fragmentation. Cells were treated with HCQ or STS (0.5mM) for 12 hours, followed by DNA fragmentation
assay; *Po0.0001.
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Autophagy has previously been defined as a process of
intracellular degradation of eukaryotic cells’ own constitu-
ents induced by starvation. Autophagy begins with the
segregation of portions of the cytoplasm within a double-
membrane-bound vacuole, called an autophagosome
(Klionsky and Ohsumi, 1999; Yoshimori, 2004). These
autophagosomes contain large amounts of microtubule-
associated LC3 protein. During the autophagic process, LC3
is recruited to the membrane for the formation of the
autophagosome and remains as the LC3-II form associated
with its membranes (Kabeya et al., 2000). Then, the
autophagosome (also called an autophagic vacuole) fuses
with a lysosome to form an autophagolysosome (Mizushima
et al., 2002), followed by degradation of the contents of the
autophagosome. Under starvation conditions or with rapa-
mycin treatment, the Atg (autophagy) 1 gene is activated and
leads to the induction of autophagy (Kamada et al., 2000).
This process has been accurately described in yeast, in which
a number of Atg genes have been identified (Kabeya et al.,
2005). Beclin-1 interacts with Atg 1 (Pattingre et al., 2008).
Isopycnic fractionation studies could show that CQ is
concentrated within the lysosome of rat embryonic fibroblasts
(Wibo and Poole, 1974). Moreover, in mouse-peritoneal
macrophages, CQ was reported to induce autophagic
vacuoles with double membranes (Fedorko et al., 1968).
Importantly, the phosphatidylinositol kinase Tor was identi-
fied as a crucial player in the starvation-signaling pathway of
autophagy (Raught et al., 2001). Accordingly, mTOR
inhibitors such as rapamycin or its derivative everolimus
induce autophagy in a nutrient-rich medium (Noda and
Ohsumi, 1998). However, these studies do not indicate that
antimalarials act as mTOR inhibitors.
Regarding the in vivo relevance of this in vitro study, it
should be noted that in this study we evaluated the effect of
HCQ on HDFs using a wide range of doses (1–100mM). Low
doses of HCQ—for example, 10 mM—affected the growth and
survival of HDFs. It was already shown that the mean blood
concentration of HCQ in patients with rheumatic arthritis
treated with a dose of approximately 224mg daily is
approximately 2.0 mM (Bondeson and Sundler, 1998). It takes
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3–4 weeks until a plasma–tissue balance is reached. Tissue
levels are 100–200 times higher than those in the plasma
(Koranda, 1981). Both CQ and HCQ are deposited in
microgram amounts per gram of skin, especially in the
epidermis. The HCQ concentration in the corium was
determined at 1.4mg per gram of skin (3.23 mM) (Shaffer
et al., 1958). Therefore, the utilized doses of HCQ in this
study are closely related to the in vivo pharmacological levels
of the drug in man.
In summary, our findings on the growth-modulatory and
autophagy-inducing effects of HCQ in HDFs in vitro warrant
further in vivo studies on the concise effect of antimalarials in
human fibrosclerotic diseases.
MATERIALS AND METHODS
Reagents
HCQ was obtained from Sanofi Aventis (Frankfurt, Germany). STS
was purchased from Sigma (Steinheim, Germany), and phorbol-12-
myristate-13-acetate (PMA) and PD98059 were purchased from
Calbiochem (Darmstadt, Germany). The rapamycin derivative ever-
olimus was a kind gift from Novartis Pharma AG (Basel, Switzer-
land); recombinant PDGF-BB and bFGF were obtained from
Immunotools (Friesoythe, Germany).
Cell culture and conditions
HDFs from neonatal foreskin were purchased from Promocell
(Heidelberg, Germany) and routinely cultured as described before
(Kokot et al., 2009a). For all experiments using HCQ, HDFs were
switched to RPMI 1640 with 2% FCS if not otherwise stated. HaCaT
cells (a kind gift from Dr Fusenig, Heidelberg) were maintained as
outlined elsewhere (Kokot et al., 2009b).
Light and electron microscopy
For phase-contrast examination, cells were exposed to HCQ at
1–100mM for various times as indicated. Images were obtained with
an inverted microscope and a digital camera (Power Shot G6,
kDa
– 60
– 85
– 26
– 85
*
Control HCQ
Anti-Beclin-1 DAPI Merge
Co
nt
ro
l
R
el
at
ive
 m
R
N
A 
ex
pr
es
sio
n
8.0
7.0
6.0
5.0
4.0
3.0
2.0
1.0
0.0
H
CQ
Anti-Beclin-1
Anti-ERK4
Anti-Bcl-2
Anti-ERK4
(hours)0 12 16
HCQ
Figure 4. Autophagic cell death by hydroxychloroquine (HCQ) in human dermal fibroblasts (HDFs) is associated with upregulation of Beclin-1. (a) Cells were
exposed to 30 mM HCQ for 6 hours, followed by real-time PCR. Gene expression was normalized using glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
as a housekeeping gene; *Po0.0001. (b) Increased Beclin-1 protein levels in HDFs after HCQ treatment. Cells were treated with 30 mM HCQ for 12 and
16hours followed by western immunoblotting using an antibody (Ab) against Beclin-1 and Bcl-2. Equal loading was ensured by membrane stripping and
reprobing with an anti-panERK Ab. (c) Subcellular distribution of Beclin-1 in HDFs exposed to HCQ as shown by immunofluorescence. Cells were exposed
to 30mM HCQ for 24 hours and incubated with an anti-Beclin-1 Ab. HDFs were subsequently incubated with a Texas red–conjugated secondary Ab and
the nuclei were stained with 4’,6-diamidino-2-phenylindole (DAPI); scale bar: 10 mm.
2424 Journal of Investigative Dermatology (2009), Volume 129
B Ramser et al.
Hydroxychloroquine Modulates Dermal Fibroblast Function
Canon, Shimomaruko, Japan). For Giemsa staining, cells were
exposed to HCQ (30 mM) or STS (0.1mM) for 8 hours in the presence of
2% FCS. After paraformaldehyde fixation and rinsing with PBS, cells
were stained with Giemsa azure eosin methylene blue solution
(Merck, Darmstadt, Germany) and were examined by light micro-
scopy (Leica DMLB, Leica, Germany). For electron microscopy cells
were exposed to STS (0.1mM) or HCQ (30 mM) for 8 hours, fixed with
5% glutaraldehyde and 4% paraformaldehyde in cacodylate buffer
for 60minutes at 4 1C, and post-fixed with 1.3% osmium tetroxide in
collidine buffer. After dehydration and embedding in Epon, thin
sections were cut by ultramicrotome (Ultracut E, Reichert-Jung,
Heidelberg, Germany), stained with lead citrate and uranyl citrate,
and photographed in an EM (CM 10, Philips, Eindhoven, The
Netherlands) at 80 kV.
Cell viability, metabolic activity, and proliferation assays
The cytotoxicity of HCQ was determined by trypan exclusion of
HDFs that had been exposed to 1–100mM HCQ for 48 hours.
Metabolic activity was measured by a Cell Proliferation Kit II (XTT;
Roche Diagnostics, Mannheim, Germany). A total of 8 103 cells
per well were plated into 96-well tissue culture plates and exposed
to 10–100mM HCQ or PD98059 (5 and 10 mM). After 48 hours,
metabolic activity was determined according to the manufacturer’s
instructions. Absorbance was measured by an Opsys MR microplate
reader (Thermo Labsystems, Frankfurt, Germany) at 490 nm.
Proliferation was assessed by 3[H]-thymidine incorporation. HDFs
seeded into 96-well tissue culture plates were exposed to HCQ
(1–100 mM) for 48 hours in the presence of 5% FCS, followed by
labeling with 1mCi/well 3[H]-thymidine for 16 hours. Radioactivity
of the detached cells was measured by a scintillation counter.
Apoptosis measurements
Apoptosis was measured by cell-death detection ELISA (CDDE;
Roche Diagnostics), Annexin-V staining, and DNA fragmentation
assay (Roche Diagnostics). For the cell-death detection assay, cells
were treated with HCQ or STS (0.5 mM). After 24 hours, adherent and
floating cells were collected and apoptosis was determined in
10,000 counted cells according to the manufacturer’s instructions.
Annexin-V staining was performed as described earlier (Bo¨hm et al.,
2005b), using the Apoptosis Detection Kit I (BD Pharmingen, San
Diego, CA). For the detection of DNA fragmentation, cells were
incubated with bromodeoxyuridine (BrdU) labeling solution over-
night at 37 1C and treated with HCQ or STS (0.5 mM) for 12 hours,
followed by cell lysis, DNA fixation, exonuclease III treatment, and
incubation with an anti-BrdU peroxidase-conjugated Ab. Samples
were then incubated in substrate solution and stop solution, followed
by photometric analysis at 450 nm according to the manufacturer’s
protocol.
Immunofluorescence analysis
HDFs seeded into eight-well chamber slides were treated with HCQ
(30 mM) for 16 or 24 hours. After methanol fixation slides were
blocked with 5% normal donkey serum (Dianova, Hamburg,
Germany) and incubated with an anti-Beclin-1 Ab (Cell Signaling
Technology, Danvers, MA) or an Ab against LC3B (Cell Signaling
Technology) for 1.5 hours at a dilution of 1:100. Negative controls
consisted of cells not treated with HCQ and cells treated with HCQ
but without incubation of the primary Ab. After being washed, cells
were incubated with a Texas red–conjugated donkey anti-rabbit IgG
(Dianova, Hamburg, Germany) at a dilution of 1:2,000. Alterna-
tively, cells were incubated with the F-actin marker fluorescein
phalloidin (Molecular Probes, Eugene, OR) at a dilution of 1:50 for
2 hours in the presence of the above secondary Ab. Finally, slides
were incubated for 5minutes at 37 1C with 40,6-diamidino-2-
phenylindole (DAPI; Fluka, Taufkirchen, Germany), mounted in
Mowiol (TER Group Terhell, Hamburg, Germany), and analyzed
with a fluorescence microscope (Carl Zeiss, Oberkochen, Germany).
Western immunoblotting
Western immunoblotting was performed as outlined before (Bo¨hm
et al., 2005a). For the detection of S6 ribosomal protein and Akt
phosphorylation, HDFs were deprived overnight in 0% FCS. Cells
were then treated with HCQ, PD98059 (10 mM), everolimus (1 nM), or
bFGF (10 ng/ml) or, alternatively, with HCQ, PDGF-BB (20 ng/ml),
or wortmannin (100 nM) for 10minutes. HDFs were harvested in
boiling 1 Laemmli buffer, sonicated, and separated by 10% SDS-
PAGE. Proteins were blotted onto polyvinylidene difluoride mem-
branes, blocked with 10% BSA (PAA, Co¨lbe, Germany), and
incubated with an anti-phospho-Thr202/Tyr204-p44/42 ERK1/2 Ab,
an anti-Akt (Thr308) Ab, an anti-Akt (Ser473) Ab, an anti-phospho-S6
ribosomal protein (Ser204/244) Ab, an anti-Beclin-1 Ab, an anti-
LC3B Ab (all from Cell Signaling Technology), or an anti-Bcl2 Ab
(Calbiochem) at the dilutions indicated by the manufacturers. Bound
Abs were detected by horseradish peroxidase–conjugated secondary
Abs (Amersham Bioscience, Buckinghamshire, UK) and ECL
(Amersham Biosciences). Equal protein loading was ensured by
membrane stripping followed by reprobing with an anti-a-tubulin Ab
(Oncogene Research Products, San Diego, CA), with an anti-ERK1/2
Ab (Cell Signaling Technology) or an anti-panERK Ab (Transduction
Laboratories, Lexington, KY).
Real-time PCR
HDFs were stimulated with HCQ at 30mM for 6 hours. Total RNA
was prepared using the RNeasy Mini Kit (Qiagen, Hilden, Germany)
according to the manufacturer’s protocol. After digestion of genomic
DNA, cDNA was synthesized employing the RevertAid FirstStrand
cDNA Synthesis Kit (Fermentas, St Leon-Rot, Germany). Real-time
PCR was subsequently performed as outlined previously (Kokot
et al., 2009a). The 40 ml master mix contained SYBR green (Absolute
SYBR Green Rox mix, Thermo Fisher Scientific, Schwerte,
Germany), 10 ml cDNA, each of the forward and reverse primers,
and H2O. The sequences for the Beclin-1 (190 bp) primers were
forward: 50-CAA GAT CCT GGA CCG TGT CA-30 and reverse: 50-
TGG CAC TTT CTG TGG ACA TCA-30 (Miracco et al., 2006).
Expression of GAPDH was used as standard. Real-time PCR was
performed with an ABI-Prism 7300 sequence detector (Applied
Biosystems, Darmstadt, Germany).
Statistical analysis
For all experiments, at least three independent experiments were
performed. Statistical significance of the data was evaluated by the
Student’s t-test. A P-value of o0.05 was considered significant.
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